NCT01005095View on ClinicalTrials.gov

The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
MULTIPLE SCLEROSIS
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

Patients will be treated daily with 800 IU of Vitamin D3 by tablets plus a bottle of 75,000 IU vitamin D3 solution every 3 weeks

DIETARY_SUPPLEMENT

Vitamin D3

Patients will receive 800 IU of vitamin D3 by tablets plus a 3 weekly placebo solution

Trial Locations (1)

Unknown

MS Clinic, Carmel Medical Center, Haifa

Sponsors
All Listed Sponsors
lead

Carmel Medical Center

OTHER

NCT01005095 - The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter